Literature DB >> 16209948

The mammalian RNA polymerase II C-terminal domain interacts with RNA to suppress transcription-coupled 3' end formation.

Syuzo Kaneko1, James L Manley.   

Abstract

RNA polymerase II plays a critical role not only in transcription of mRNA precursors but also in their subsequent processing. This later function is mediated primarily by the C-terminal domain (CTD) of the enzyme's largest subunit, a unique, repetitive structure conserved throughout eukaryotes and known to interact with a number of different proteins during the transcription cycle. Here, we show that the mammalian CTD also interacts with RNA in a sequence-specific manner. We use a variety of RNA binding assays, including SELEX, to characterize the interaction in vitro and a modified chromatin immunoprecipitation (ChIP) assay to provide evidence that it also occurs in vivo. Transfection assays with the CTD binding consensus situated downstream of a polyadenylation signal indicate that the sequence can suppress mRNA 3' end formation and transcription termination, and in vitro assays indicate that the inhibition of processing is CTD dependent. Our results provide an unexpected function for CTD in modulating gene expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209948     DOI: 10.1016/j.molcel.2005.08.033

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  23 in total

1.  RNA-binding protein L1TD1 interacts with LIN28 via RNA and is required for human embryonic stem cell self-renewal and cancer cell proliferation.

Authors:  Elisa Närvä; Nelly Rahkonen; Maheswara Reddy Emani; Riikka Lund; Juha-Pekka Pursiheimo; Juuso Nästi; Reija Autio; Omid Rasool; Konstantin Denessiouk; Harri Lähdesmäki; Anjana Rao; Riitta Lahesmaa
Journal:  Stem Cells       Date:  2012-03       Impact factor: 6.277

2.  Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing.

Authors:  Bin Tian; Zhenhua Pan; Ju Youn Lee
Journal:  Genome Res       Date:  2007-01-08       Impact factor: 9.043

3.  RNA-based affinity purification reveals 7SK RNPs with distinct composition and regulation.

Authors:  J Robert Hogg; Kathleen Collins
Journal:  RNA       Date:  2007-04-24       Impact factor: 4.942

4.  Cotranscriptional splicing potentiates the mRNA production from a subset of estradiol-stimulated genes.

Authors:  Danielle Bittencourt; Martin Dutertre; Gabriel Sanchez; Jérôme Barbier; Lise Gratadou; Didier Auboeuf
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

Review 5.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

Review 6.  Signals for pre-mRNA cleavage and polyadenylation.

Authors:  Bin Tian; Joel H Graber
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-10-19       Impact factor: 9.957

7.  The non-coding B2 RNA binds to the DNA cleft and active-site region of RNA polymerase II.

Authors:  Steven L Ponicsan; Stephane Houel; William M Old; Natalie G Ahn; James A Goodrich; Jennifer F Kugel
Journal:  J Mol Biol       Date:  2013-02-08       Impact factor: 5.469

8.  FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2.

Authors:  Jacob C Schwartz; Christopher C Ebmeier; Elaine R Podell; Joseph Heimiller; Dylan J Taatjes; Thomas R Cech
Journal:  Genes Dev       Date:  2012-12-15       Impact factor: 11.361

9.  Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis.

Authors:  Bin Xu; Wei-Hsiung Yang; Isabelle Gerin; Chang-Deng Hu; Gary D Hammer; Ronald J Koenig
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

Review 10.  Riboactivators: transcription activation by noncoding RNA.

Authors:  Aseem Z Ansari
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Jan-Feb       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.